Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT02277743. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Confirmatory Study Investigating the Efficacy and Safety of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, placebo-controlled, parallel group study to confirm the efficacy and safety of Dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis (AD).
Study identification
- NCT ID
- NCT02277743
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 671 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2014 (Type not available)
- Primary completion
- Nov 2015 (Actual)
- Completion
- Feb 2016 (Actual)
- Last update posted
- Nov 21, 2017
2014 – 2016
United States locations
- U.S. sites
- 45
- U.S. states
- 21
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Fort Smith | Arkansas | — | — |
| Not listed | Rogers | Arkansas | — | — |
| Not listed | Clovis | California | — | — |
| Not listed | Lomita | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Oceanside | California | — | — |
| Not listed | Palmdale | California | — | — |
| Not listed | Rolling Hills Estates | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Santa Monica | California | — | — |
| Not listed | Stockton | California | — | — |
| Not listed | Boca Raton | Florida | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Miami Lakes | Florida | — | — |
| Not listed | Pensacola | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Newnan | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Normal | Illinois | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | Boston | Massachusetts | — | — |
| Not listed | Troy | Michigan | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Newington | New Hampshire | — | — |
| Not listed | East Windsor | New Jersey | — | — |
| Not listed | Buffalo | New York | — | — |
| Not listed | Corning | New York | — | — |
| Not listed | New Hyde Park | New York | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | High Point | North Carolina | — | — |
| Not listed | Bethlehem | Pennsylvania | — | — |
| Not listed | Upland | Pennsylvania | — | — |
| Not listed | Chattanooga | Tennessee | — | — |
| Not listed | Knoxville | Tennessee | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Waco | Texas | — | — |
| Not listed | Ogden | Utah | — | — |
| Not listed | Newport News | Virginia | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02277743, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 21, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02277743 live on ClinicalTrials.gov.